Neurocognitive Dysfunction Clinical Trials

6 recruiting

Neurocognitive Dysfunction Trials at a Glance

8 actively recruiting trials for neurocognitive dysfunction are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in San Diego, Brescia, and Genk. Lead sponsors running neurocognitive dysfunction studies include Fondazione Don Carlo Gnocchi Onlus, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, and First Affiliated Hospital of Kunming Medical University.

Browse neurocognitive dysfunction trials by phase

Treatments under study

About Neurocognitive Dysfunction Clinical Trials

Looking for clinical trials for Neurocognitive Dysfunction? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neurocognitive Dysfunction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neurocognitive Dysfunction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

The Role of Neuroinflammation on Neurocognitive Outcome in Cardiac Surgery

Postoperative Neurocognitive DisorderElderly PatientsCardiac Surgery+4 more
Ziekenhuis Oost-Limburg80 enrolled1 locationNCT07200726
Recruiting
Not Applicable

Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)

Brain TraumaNeurocognitive DysfunctionMild Cognitive Impairment+8 more
United States Naval Medical Center, San Diego160 enrolled2 locationsNCT06413173
Recruiting

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Cognitive ImpairmentDementiaCognitive Dysfunction+7 more
Mclean Hospital40 enrolled1 locationNCT05245903
Recruiting

Early Severe Illness TrAnslational BioLogy InformaticS in Humans

SepsisCritical IllnessNeurocognitive Dysfunction+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1,000 enrolled1 locationNCT05591924
Recruiting
Phase 3

Evaluation of Memantine in the Preservation of Memory and Neurocognition Following CSI

Neurocognitive Dysfunction
Tata Memorial Centre101 enrolled1 locationNCT06275035
Recruiting
Not Applicable

Assessing Neurocognition After Cerebrovascular Intervention

Neurocognitive DysfunctionCarotid Artery Diseases
University of California, San Diego20 enrolled1 locationNCT03344276
Recruiting
Not Applicable

The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders

Sclerosis, MultipleNeurocognitive Impairment, MildNeurocognitive Dysfunction
Fondazione Don Carlo Gnocchi Onlus192 enrolled3 locationsNCT06112639
Recruiting

Perioperative IL-33 is Associated with the Early Stage of Postoperative Neurocognitive Dysfunction After Major Abdominal Surgery

Cognitive DysfunctionPostoperative ComplicationsNeuropsychological Tests+1 more
First Affiliated Hospital of Kunming Medical University150 enrolled1 locationNCT06704451